3 06, 2021 Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addictionadmin2021-06-02T19:52:19-04:00June 3rd, 2021|Press Release| Read More
2 06, 2021 Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conferenceadmin2021-05-29T14:00:41-04:00June 2nd, 2021|Press Release| Read More
27 05, 2021 Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Sharesadmin2021-05-27T14:05:31-04:00May 27th, 2021|Press Release| Read More
25 05, 2021 Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offeringadmin2021-05-25T00:08:31-04:00May 25th, 2021|Press Release| Read More
24 05, 2021 Achieve Life Sciences Announces Proposed Underwritten Public Offeringadmin2021-05-24T14:53:17-04:00May 24th, 2021|Press Release| Read More
13 05, 2021 Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Updateadmin2021-05-12T17:01:47-04:00May 13th, 2021|Press Release| Read More
4 05, 2021 Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021admin